ESMO 2012 News

Welcome to ESMO 2012 news. Here you will find a selection of articles that appeared in the ESMO 2012 newspaper, Congress Daily, which was distributed to attendees of the ESMO congress in Vienna.

Complete copies of the four newspapers are available for download as PDF files

Filter

Date Title Topic
01 Oct 2012 PM01183: A promising new drug for ovarian cancer Genitourinary cancers
01 Oct 2012 Successes and failures: Do targeted therapies live up to their promise? Anticancer agents & Biologic therapy
01 Oct 2012 PHARE trial results comparing 6 to 12 months of adjuvant trastuzumab in early breast cancer Breast cancer
01 Oct 2012 How to hunt for a primary tumour site Personalised medicine
01 Oct 2012 Updated results of HERA study: Extending trastuzumab for 2 years does not improve outcomes versus 1-year treatment Breast cancer
30 Sep 2012 Case for including patients with brain metastases in clinical trials Head and neck cancers
30 Sep 2012 EXPAND study shows no benefit from adding cetuximab to the first-line chemotherapy in advanced gastric cancer Gastrointestinal cancers
30 Sep 2012 Patient rights and obligations Bioethics, legal and economic issues
30 Sep 2012 Analysis of NeoALTTO trial data: Too few women being offered breast-conserving treatment Breast cancer
30 Sep 2012 Novel hypoxia drug shows promise in pancreatic cancer Gastrointestinal cancers
30 Sep 2012 ESMO holds first session dedicated to Community Oncologists Anticancer agents & Biologic therapy
30 Sep 2012 Dual therapy shows potential in melanoma Melanoma and other skin tumours
30 Sep 2012 ARADES: A first-in-man study of ODM-201 Genitourinary cancers
30 Sep 2012 Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive advanced NSCLC Lung and other thoracic tumours
30 Sep 2012 Survey reveals ‘global pandemic’ of untreated cancer pain Personalised medicine - Palliative and supportive care